FP
CTSO icon

Financial Perspectives’s Cytosorbents Corp CTSO Stock Holding History

Financial Perspectives’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,000
Closed -$8.12K – 658
2021
Q3 		$8.12K Hold
1,000
– – ﹤0.01% 466
2021
Q2 		$7.55K Sell
1,000
-7,680
-88% -$64.7K ﹤0.01% 491
2021
Q1 		$1M Buy
+8,680
New +$82.7K 0.05% 208

Other funds holding CTSO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
AC
Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Financial Perspectives's CTSO Position: Q4 2021 in Review

Financial Perspectives sold out of Cytosorbents Corp (CTSO) in Q4 2021, closing a stake of 1,000 shares — an estimated $8.12K sold.

Financial Perspectives first reported a position in CTSO in Q1 2021 and held it in 3 quarters. The position peaked at $1M in Q1 2021. 91 funds tracked by Wall St. Rank hold CTSO as of Q4 2021.

  • Financial Perspectives reported no remaining Cytosorbents Corp position as of Q4 2021 after selling out during the quarter.
  • Financial Perspectives sold 1,000 Cytosorbents Corp shares in Q4 2021, an estimated $8.12K.
  • Financial Perspectives first reported a position in Cytosorbents Corp in Q1 2021 and held it in 3 quarters.
  • Financial Perspectives's Cytosorbents Corp position peaked at $1M in Q1 2021.
  • 91 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q4 2021.

Based on Financial Perspectives's 13F filing for Q4 2021, filed 10 Jan 2024.